Ryan Spencer - 18 Jul 2024 Form 4 Insider Report for Cidara Therapeutics, Inc. (CDTX)

Role
Director
Signature
/s/ Shane Ward, Attorney-in-Fact
Issuer symbol
CDTX
Transactions as of
18 Jul 2024
Transactions value $
$0
Form type
4
Filing time
19 Jul 2024, 16:40:06 UTC
Previous filing
30 Apr 2024
Next filing
12 Feb 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDTX Stock Option (right to buy) Award $0 +2,125 $0 2,125 18 Jul 2024 Common Stock 2,125 $12.64 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant or (ii) the day prior to the date of the Issuer's 2025 annual meeting of stockholders.